1 |
amphetamine
(920 times)
|
Neurology (306 times)
|
DA (272 times) NAc (63 times) DAT (57 times)
|
1975 Intracellular distribution of amines taken up by rat mast cells.
|
2 |
amphotericin B
(45 times)
|
Microbiology (9 times)
|
MCZ (8 times) FLCZ (7 times) FCZ (5 times)
|
1984 [Clinical study of miconazole in deep-seated fungal infections].
|
3 |
d-amphetamine sulphate
(19 times)
|
Behavioral Sciences (8 times)
|
DA (8 times) DOPAC (2 times) HVA (2 times)
|
1985 Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.
|
4 |
aminophylline
(8 times)
|
Pharmacology (3 times)
|
AED (1 time) alpha-EMTBL (1 time) BAL (1 time)
|
1983 Neonatal apnea, xanthines, and necrotizing enterocolitis.
|
5 |
administration of dexamphetamine
(4 times)
|
Physiology (2 times)
|
3-NT (1 time) AG (1 time) CAT (1 time)
|
1980 Investigations on the interaction between cyproheptadine and amphetamine.
|
6 |
amphiphysin
(3 times)
|
Nervous System Diseases (1 time)
|
AD (1 time) AQP4 (1 time) ARPP21 (1 time)
|
2009 The deduced structure of the T cell receptor gamma locus in Canis lupus familiaris.
|
7 |
1-acetyl-1-methyl-2-phenylhydrazide
(2 times)
|
Biology (2 times)
|
AAA (2 times) FAA (2 times) AMDOPH (1 time)
|
2007 Investigation of the behavior and metabolism of pharmaceutical residues during purification of contaminated ground water used for drinking water supply.
|
8 |
Acute massive pulmonary hemorrhage
(2 times)
|
Allergy and Immunology (1 time)
|
SLE (2 times) IICP (1 time) NPE (1 time)
|
1994 Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide.
|
9 |
mg/kg (+)-amphetamine
(2 times)
|
Psychopharmacology (1 time)
|
APO (1 time) DS (1 time) FEN (1 time)
|
1990 Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.
|
10 |
self-administered S(+)-amphetamine
(2 times)
|
Pharmacology (1 time)
|
MDA (1 time)
|
1980 Development of tolerance to the rewarding effects of self-administered S(+)-amphetamine.
|
11 |
achieved, the effects of dextroamphetamine
(1 time)
|
Neurology (1 time)
|
5-CSRTT (1 time) DOI (1 time) ITIs (1 time)
|
2017 Influence of intertrial interval on basal and drug-induced impulsive action in the 5-choice serial reaction time task: Effects of d-amphetamine and ()-2,5-dimethoxy-4-iodoamphetamine (DOI).
|
12 |
adenosine-5(')-monophosphate
(1 time)
|
Biophysics (1 time)
|
VDE (1 time)
|
2008 Photoelectron spectroscopy of the parent anions of the nucleotides, adenosine-5'-monophosphate and 2'deoxyadenosine-5'-monophosphate.
|
13 |
administered to four monkeys trained to discriminate (+)-amphetamine
(1 time)
|
Psychopharmacology (1 time)
|
FR 25 (1 time) MA (1 time)
|
2001 Reinforcing and discriminative stimulus effects of RTI 111, a 3-phenyltropane analog, in rhesus monkeys: interaction with methamphetamine.
|
14 |
adolescent mental and physical health
(1 time)
|
Public Health (1 time)
|
AMH (1 time) APH (1 time)
|
2012 Adolescent mental and physical health in the English-speaking Caribbean.
|
15 |
agent D-(+)-am-phetamine
(1 time)
|
Drug Therapy (1 time)
|
DA (1 time)
|
1989 Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
|
16 |
agonist, (+)-amphetamine
(1 time)
|
Brain (1 time)
|
SN (1 time)
|
1991 Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.
|
17 |
AMPH cross-sensitization
(1 time)
|
Medicine (1 time)
|
DA (1 time) FAA (1 time) LS (1 time)
|
2017 Exploring the role of locomotor sensitization in the circadian food entrainment pathway.
|
18 |
amphetamine-induced hyperactivity
(1 time)
|
Psychopharmacology (1 time)
|
CDP (1 time)
|
2009 The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers.
|
19 |
amphiphysin gene
(1 time)
|
Genetics, Medical (1 time)
|
---
|
1995 Genetic mapping of the human amphiphysin gene (AMPH) at 7p14-p13 excludes its involvement in retinitis pigmentosa 9 or dominant cystoid macular dystrophy.
|
20 |
angular-multiplexing polarization hologram
(1 time)
|
Biophysics (1 time)
|
---
|
2017 Fiber-based lensless polarization holography for measuring Jones matrix parameters of polarization-sensitive materials.
|
21 |
Animals received various doses of S(+)-amphetamine
(1 time)
|
Brain (1 time)
|
DA (1 time) HAL (1 time) PCPA (1 time)
|
1979 Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
|
22 |
animals, dextroamphetamine
(1 time)
|
Brain (1 time)
|
FM (1 time)
|
2005 Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial.
|
23 |
anti-amphiphysin
(1 time)
|
|
NSCLC (1 time) PNS (1 time)
|
2021 A case of non-small cell lung cancer presenting anti-amphiphysin antibody-positive paraneoplastic neurological syndrome.
|
24 |
application of the d(+)-amphetamine
(1 time)
|
Pharmacology (1 time)
|
CN (1 time) EPS (1 time) NAL (1 time)
|
1983 Effects of naloxone on dopamine release in the nigrostriatal system.
|
25 |
aspects of D: -amphetamine
(1 time)
|
Psychopharmacology (1 time)
|
BLA (1 time) CART (1 time) CPA (1 time)
|
2009 The effects of infusions of CART 55-102 into the basolateral amygdala on amphetamine-induced conditioned place preference in rats.
|
26 |
Bath-applied (+)-amphetamine
(1 time)
|
Brain (1 time)
|
DA (1 time) VTA (1 time)
|
1991 Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro.
|
27 |
D-amphetamine bitartrate
(1 time)
|
Biochemistry (1 time)
|
CPZ (1 time)
|
1988 Amphetamine and chlorpromazine modify cerebral insulin levels in rats.
|
28 |
dextro-amphetamine sulfate
(1 time)
|
Psychiatry (1 time)
|
---
|
2015 Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke.
|
29 |
N'-acetyl-4-(hydroxymethyl)phenylhydrazine
(1 time)
|
Environmental Health (1 time)
|
4-MPH (1 time)
|
1981 Studies of the tumorigenic potential of 4-substituted phenylhydrazines by the subcutaneous route.
|
30 |
repeated-amphetamine
(1 time)
|
Neurology (1 time)
|
---
|
2007 Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia.
|